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Abstract 
Background: Blood transfusion is an integral part in the management of sickle cell disease 
patients. Allogeneic blood transfusion is a form of temporary transplantation. A recipient often 
mounts an immune response to the donor antigens resulting in various clinical consequences 
including delayed hemolytic transfusion reactions. Delayed reaction is often seen in individuals 
who have received repeated transfusion of ABO compatible blood that incompatible for other blood 
group antigens because of minor allelic difference stimulate the production of IgG antibodies. In the 
patients who have sickle cell disease the majority of tests may have low sensitivity and in turn may 
fail to show the autoantibodies.  
Objectives: This study has been conducted for detection of allo-antibodies in patient with sickle 
cell anaemia and hemophilia who received repeated blood transfusions using newly introduced test 
system; the DiaMed-Immuno-Diffusion microtyping system.  
Methods: Samples were collected randomly from 60 patients with repeated blood transfusions. 
Micro column gel test as well as agglutination method were performed for all samples. All the 
results were analyzed using Statistical Packages of Social Sciences (SPSS).  
Results and Discussion: This test provides clear and stable reactions that improve result 
interpretation. It proved to be more sensitive than the conventional tube agglutination technique as 
it captures agglutinate in a semi solid medium and on the other hand it has the capacity to detect 
unexpected antibodies. This in turn enhances visibility of agglutination compared to the traditional 
Tube techniques.  
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he major barrier to successful blood 
transfusion is the immune responses to 
the cell surface molecules that differ 
between individuals; the most important allo-
antigen system in blood transfusion is the 
ABO system1,2. One of the main 
complications of red blood cells (RBCs) 
transfusion is the development of 
alloimmunization to RBCs antigens3,4. 
Among serious complication of 
alloimmunization is delayed hemolytic 
transfusion reaction/hyperhemolysis 
(DHTR/H) syndrome5,6.  
The transfused blood induces clonal selection 
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 and production of IgG against common 
membrane antigens e.g. Rh Kidd, kell and 
Duffy blood groups. IgG is less effective than 
IgM in activating complement so the lysis is 
incomplete and many of the transfused cells 
are destroyed at extravascular sites by 
agglutination opsonization and sub sequent 
phagocytes by macrophages. This has mostly 
been described in sickle cell anemia7-10 but 
occasionally in beta-thalassemia11. The 
antibodies to minor antigen (unexpected 
antibodies) are capable of causing hemolytic 
transfusion reactions12.On the other hand, 
antibodies may triggers an immediate 
hemolytic reaction, resulting in both 
intravascular lysis of red blood cells probably 
mediated by the complement system, and 
extensive phagocytes of antibody- and 
complement- coated erythrocytes by 
macrophages of the liver and spleen13.  
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However, in the patients who have sickle cell 
disease the majority of tests may have low 
sensitivity and in turn may fail to show the 
autoantibodies14, 15. In the 1990s, the micro 
column gel technique was introduced for 
screening and identification of such 
unexpected antibodies16. This method is not 
only easy to perform but, also easy to 
standardize and read, so it has become the 
most common technique in the blood bank 
laboratories of many countries.  
Objectives: This study aimed to assess the 
ability of agglutination test to detect 
alloantibodies using conditional ratios 
(sensitivity, specifity, positive and negative 
predictive values and accuracy). Probably, 
this is the first study in Sudan in this field. 
 
Patients and Methods: 
 
Ethical consideration The study had 
received an ethical approval from the ethical 
review committee at the Institute of Tropical 
Medicine University of Sudan academy. The 
samples were collected (the donated units) by 
well trained medical laboratory technicians at 
the blood banks. 
Study population The study was conducted 
in 60 patients with repeated blood 
transfusions. Patients were recruited from 
Khartoum Teaching Hospital and Children 
Emergency Hospital. Serum samples were 
considered for analysis following obtaining 
formal consent from blood donors then, has 
been cryopreserved until using at -20ºC. 
Diamed - id micro typing system and 
agglutination method: Micro column gel test 
was done as essentially prescribed by 
Lapierre et al., 199016. Agglutination method 
was also performed for all samples using tube 
agglutination technique. 
Data Analysis: Statistical analysis was 
performed with statistical software SPSS for 
Windows (version 17.0).  Crosstabulation was 
performed for the findings of agglutination 
and immunodiffusion tests. The conditional 
ratios (sensitivity, specifity, positive and 
negative predictive values and accuracy) were 
calculated for agglutination test accordingly. 
 
Results 
The study involved 60 patients with repeated 
blood transfusions. Fifty patients (83.4%) 
were suffering from sickle cell anemia. The 
rest were suffering from hemophilia (10%) 
thrombocytopenia (3.3%) and other types of 
anemias (3.3%). Forty patients (67.7%) 
underwent five or more blood transfusions. 
Nine patients (15%) of studied patients were 
having alloantntibodies according to the 
immunodiffusion test. Only 22.2 % of 
positive immunodiffusion test, were also 
positive when using agglutination test   
(figure 1). 
 






Agglutination Test Positive 22.20% 100%
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Table-1 summarizes the agglutination test 
true positives and true negatives samples 
based on the results of immunodiffusion test. 
Taking into consideration the very high 
capability of immunodiffusion test to detect 
alloantibodies, the conditional ratios were 
calculated for agglutination test and are given 
underneath table 1. Agglutination test has a 
very high specifity and positive predictive 
value (PPV) (100% for both). On the other 
hand, negative predictive value (NPV) 
reaches 87.9% and Sensitivity drops to 
22.2%. The accuracy of agglutination test to 
detect alloantibodies is found to be 88.3%.
 
Table-1: Detection rate of  alloantibody in patients with repeated blood transfusion 
 
 Immunodiffusion Test Positive Negative Total 
Agglutination 
Test 
Positive 2 0 2 
Negative 7 51 58 
Total 9 51 60 
Pearson Chi-Square value = 11.72 
P = 0.001 
Sensitivity = 22.2% 
Specifity = 100% 
Positive predictive value = 100% 
Negative predictive value = 87.9% 
Accuracy = 88.3% 
 
Discussion: 
Usually the tube technique has been 
employed to detect the presence of 
alloantibodies in particular those have the 
capacity to induce delayed haemolysis. 
Nevertheless a lot of experiments may be 
needed for detection of such antibodies. In an 
attempt to overcome this practical difficulty 
of the Tube technique, the DiaMed-ID® 
micro typing system (ID – gel test) was 
introduced by Lapierre16 and is now 
commercially available in Sudan.  
Patients of this study developed at least 2-3 
episodes of delayed hemolysis occurring not 
less than 10 days after RBC transfusion. The 
tube agglutination test detected four allo-
antibodies and the immune-diffusion gel test 
detected nine allo-antibodies. Agglutination 
test achieved 100% specificity, however, this 
extremely high specificity score was at the 
expense of sensitivity, which achieved 
incredibly poor performance (22.2%). The 
specificity of a test is the probability that a 
test will produce a true negative result when 
used in a patients with no alloantibodies (as 
determined by immunodiffusion test) while 
sensitivity is the probability that the test will  
 
produce a true positive result when used in 
patients with alloantibodies  
Regarding predictive values, Agglutination 
test achieved 100% PPV, not far away NPV 
drops to 87.9%. PPV refer to the probability 
that a person has alloantibodies when a 
positive test result is observed while NPV is 
the probability that a person has no 
alloantibodies when the test result is negative. 
Although, PPV is very good in this study, 
agglutination test failed to diagnose 77.8% of 
immunodiffusion test positive samples. This 
explains the relatively lower scores of NPV 
and sensitivity. However, it is worth 
mentioning that in practice, predictive values 
should only be calculated from cohort studies 
or studies that legitimately reflect the number 
of people in that population who have the 
disease of interest at that time. This is because 
predictive values are inherently dependent 
upon the prevalence of the disease. 
Diagnostic likelihood ratios are not yet 
commonly reported in peer-reviewed 
literature, but they can be a valuable tool for 
comparing the accuracy of several tests to the 
gold standard, and they are not dependent 
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upon the prevalence of disease. The positive 
diagnostic likelihood ratio (PDLR) of 
agglutination test = 22.2/0 = ∞. PDLR 
represents the odds ratio that a positive test 
result will be observed in population with 
alloantibodies compared to the odds that the 
same result will be observed among a 
population with no alloantibodies. In the 
current study, PDLR is very high indicating 
the usefulness of agglutination test. This is 
because the less useful tests will have smaller 
values. The negative diagnostic likelihood 
ratio (PDLR) = 7/51 = 0.13. NDLR represents 
the odds ratio that a negative test result will 
be observed in patients with no alloantibodies 
compared to the odds that the same result will 
be observed among patients with no 
alloantibodies. Useful tests will, therefore, 
have NDLR close to zero making the current 
result moderately satisfactory. 
Conclusion  
The use of gel test has increased the number 
of antibodies detected. The accuracy (i.e. the 
proportion of both true positives and true 
negatives) of agglutination test to detect 
presence or absence of alloantibodies was 
found to be 88.3%. Although there are no 
false positive samples, the false negative rate 
reached 77.8%. Although agglutination test 
reduces transfusion reactions, transfusion of 
agglutination test negative blood can still 
induce post-transfusion reactions. Therefore, 
screening for unexpected antibodies using 
Immuno-Diffusion microtyping system 
should be part of all pre-transfusion testing. 
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